In Vivo Requirement for Atg5 in Antigen Presentation by Dendritic Cells
Autophagy is known to be important in presentation of cytosolic antigens on MHC class II (MHC II). However, the role of autophagic process in antigen presentation in vivo is unclear. Mice with dendritic cell (DC)-conditional deletion in Atg5, a key autophagy gene, showed impaired CD4 + T cell primin...
Saved in:
Published in: | Immunity (Cambridge, Mass.) Vol. 32; no. 2; pp. 227 - 239 |
---|---|
Main Authors: | , , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
United States
Elsevier Inc
26-02-2010
Elsevier Limited |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Autophagy is known to be important in presentation of cytosolic antigens on MHC class II (MHC II). However, the role of autophagic process in antigen presentation in vivo is unclear. Mice with dendritic cell (DC)-conditional deletion in Atg5, a key autophagy gene, showed impaired CD4
+ T cell priming after herpes simplex virus infection and succumbed to rapid disease. The most pronounced defect of
Atg5
−/− DCs was the processing and presentation of phagocytosed antigens containing Toll-like receptor stimuli for MHC class II. In contrast, cross-presentation of peptides on MHC I was intact in the absence of Atg5. Although induction of metabolic autophagy did not enhance MHC II presentation, autophagic machinery was required for optimal phagosome-to-lysosome fusion and subsequent processing of antigen for MHC II loading. Thus, our study revealed that DCs utilize autophagic machinery to optimally process and present extracellular microbial antigens for MHC II presentation.
► DCs use autophagy machinery to process exogenous microbial antigens for MHC II ► Canonical autophagy is not required for processing of phagocytosed antigens ► Mice with Atg5 deletion in DCs fail to induce Th1 cells and succumb to HSV infection |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Article-2 ObjectType-Feature-1 Present address: Program in Cell Biology, Hospital for Sick Children, Toronto, Ontario, Canada Present address: Department of Radiation Oncology, Seoul St. Mary’s Hospital, The Catholic University of Korea, Seoul, Korea Present address: Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, 305-701, Republic of Korea |
ISSN: | 1074-7613 1097-4180 |
DOI: | 10.1016/j.immuni.2009.12.006 |